Stock PRLD PRELUDE THERAPEUTICS INCORPORATED
Add to a list
To use this feature you must be a member
Log inSign up

Revisions Prelude Therapeutics Incorporated

Equities

PRLD

US74065P1012

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
4.07 USD +0.74% Intraday chart for Prelude Therapeutics Incorporated +9.41% -4.68%
Apr. 10 Bryant D. Lim to Serve as Principal Financial Officer and Principal Accounting Officer of Prelude Therapeutics Incorporated CI
Apr. 10 Prelude Therapeutics Incorporated Announces Chief Financial Officer Changes CI

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Cash or Net Debt - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

Cash or Net Debt

  1. Stock Market
  2. Equities
  3. PRLD Stock
  4. Revisions Prelude Therapeutics Incorporated